Literature DB >> 16255115

Delays in treatment in the cancer services: impact on cancer stage and survival.

H Comber1, D P Cronin, S Deady, P O Lorcain, P Riordan.   

Abstract

This study describes waiting times for cancer treatment in Ireland, tests for differences between health board areas and investigates if delay affected cancer stage or prognosis. We measured the times between referral, outpatient attendance and treatment for all patients diagnosed with five common cancers in Ireland in 1999. There was a four-fold spread of waiting time between the 25th and 75th centile. The time from referral to treatment was shortest for breast cancer (median 4 weeks), twice this for colorectal cancer, lung cancer and lymphoma, and 15 weeks for prostate cancer. Delays varied significantly, but not consistently, between health boards. Patients with longer waiting times generally had less advanced disease and better survival, suggesting that typical delays are not of clinical significance, but that patients with advanced disease are probably being "fast-tracked" by GPs and hospitals.

Entities:  

Mesh:

Year:  2005        PMID: 16255115

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  19 in total

1.  The relationship of cancer characteristics and patient outcome with time to lung cancer diagnosis after an abnormal screening CT.

Authors:  Sushilkumar K Sonavane; Paul Pinsky; Jubal Watts; David S Gierada; Reginald Munden; Satinder P Singh; Hrudaya Nath
Journal:  Eur Radiol       Date:  2017-06-14       Impact factor: 5.315

2.  Young adults' experiences with cancer: comments from patients and survivors.

Authors:  Baukje Bo Miedema; Julie Easley; Ryan Hamilton
Journal:  Can Fam Physician       Date:  2006-11       Impact factor: 3.275

3.  Racial Differences in Time to Breast Cancer Surgery and Overall Survival in the US Military Health System.

Authors:  Yvonne L Eaglehouse; Matthew W Georg; Craig D Shriver; Kangmin Zhu
Journal:  JAMA Surg       Date:  2019-03-20       Impact factor: 14.766

Review 4.  Guideline for referral of patients with suspected colorectal cancer by family physicians and other primary care providers.

Authors:  M Elisabeth Del Giudice; Emily T Vella; Amanda Hey; Marko Simunovic; William Harris; Cheryl Levitt
Journal:  Can Fam Physician       Date:  2014-08       Impact factor: 3.275

5.  Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.

Authors:  Colin T Murphy; Thomas J Galloway; Elizabeth A Handorf; Brian L Egleston; Lora S Wang; Ranee Mehra; Douglas B Flieder; John A Ridge
Journal:  J Clin Oncol       Date:  2015-11-30       Impact factor: 44.544

6.  Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study.

Authors:  Pramit Nadpara; S Suresh Madhavan; Cindy Tworek
Journal:  Cancer Epidemiol       Date:  2015-06-29       Impact factor: 2.984

7.  Time to Surgery and Breast Cancer Survival in the United States.

Authors:  Richard J Bleicher; Karen Ruth; Elin R Sigurdson; J Robert Beck; Eric Ross; Yu-Ning Wong; Sameer A Patel; Marcia Boraas; Eric I Chang; Neal S Topham; Brian L Egleston
Journal:  JAMA Oncol       Date:  2016-03       Impact factor: 31.777

8.  [Survival of patients diagnosed with prostate cancer and monitored in primary care].

Authors:  Gabriel J Díaz Grávalos; Gerardo Palmeiro Fernández; Inmaculada Casado Górriz; Margarita Arandia García; Susana Alvarez Araújo; Mónica González Dacosta
Journal:  Aten Primaria       Date:  2007-11       Impact factor: 1.137

9.  Measurement of surgical wait times in a universal health care system.

Authors:  Jun Kawakami; Wilma M Hopman; Rachael Smith-Tryon; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2008-12       Impact factor: 1.862

10.  Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  David E Ost; Sai-Ching Jim Yeung; Lynn T Tanoue; Michael K Gould
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.